EUVIMEDEUVIMED entdecken
Crossref

Determining patient preferences in the treatment of medication‐refractory overactive bladder

Jacqueline Speed iD, Blayne Welk iD, Craig Comiter iD, Christopher Elliott iD

Neurourology and Urodynamics · 2023-02 · 42 (2) · 419-426

DOI: 10.1002/nau.25109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 08.12.2022. Verfasst von Jacqueline Speed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Electric Stimulation Therapy, Transcutaneous Electric Nerve Stimulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Overactive bladder (OAB) is often suboptimally addressed by behavioral or pharmacological treatments. Less than 15% of patients choose to pursue advanced OAB therapy (sacral nerve stimulation [SNS], percutaneous tibial nerve stimulation [PTNS], and bladder onabotulinum toxin type‐A [BTX‐A]). We seek to better understand which factors are most important to patients when choosing a third‐line therapy. Methods/Materials We developed a conjoint analysis survey that included five attributes of the third‐line options for OAB (SNS, PTNS, and BTX‐A). We administered the survey to new patients with urinary incontinence at two institutions. A hierarchical Bayes random effects regression analysis was used to determine the relative importance of the attributes. A choice simulator was used to model which third‐line treatment options patients preferred. We followed patients to see if they pursued their predicted treatment.

Results

A total of 108 patients completed the study of whom 89% were women. There was representation from all age groups. The most important attributes of decision‐making were the frequency of future procedures, the risk of catheterization, and the need for a device. On market simulation, SNS was the preferred treatment option (47%), followed by PTNS (29%) and BTX‐A (14%). Only 10% of patients did not find any treatment option acceptable.

Conclusions

Frequent follow‐up, risk of catheterization, and the need for a device were the most important attributes when making a decision on third‐line OAB therapy. On market simulation, SNS is the preferred treatment for all age groups though the ultimate choice in third‐line therapy may be affected by external factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveElectric Stimulation TherapyTranscutaneous Electric Nerve StimulationHumansFemaleMalePatient PreferenceBayes TheoremTibial NerveTreatment Outcome

Stichwörter der Autor:innen

conjoint analysisoveractive bladderpatient decision-makingthird-line therapies

Autor:innen und Institutionen

  • Department of Urology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Surgery, North Shore Physicians Group, Salem, Massachusetts, USA.
  • Department of Surgery, St. Joseph's Hospital, London, Ontario, Canada.
  • Department of Urology, Santa Clara Valley Medical Center, Santa Clara, California, USA.

ORCID-Profile: Jacqueline Speed, Blayne Welk, Craig Comiter, Christopher Elliott

Förderung

  • Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Foundation

Zitieren

APA

Speed, J., Welk, B., Comiter, C., & Elliott, C. (2023). Determining patient preferences in the treatment of medication‐refractory overactive bladder. Neurourology and Urodynamics, 42(2), 419-426. https://doi.org/10.1002/nau.25109

Vancouver

Speed J, Welk B, Comiter C, Elliott C. Determining patient preferences in the treatment of medication‐refractory overactive bladder. Neurourology and Urodynamics. 2023;42(2):419-426. doi:10.1002/nau.25109

BibTeX
@article{Speed2023,
  author = {Speed, Jacqueline and Welk, Blayne and Comiter, Craig and Elliott, Christopher},
  title = {Determining patient preferences in the treatment of medication‐refractory overactive bladder},
  journal = {Neurourology and Urodynamics},
  year = {2023},
  volume = {42},
  number = {2},
  pages = {419--426},
  doi = {10.1002/nau.25109}
}
Kostenlos starten →